Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma-Reference-Cited by-同舟云学术

Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

Published:2018-11-26 Issue:1 Volume:19 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Méndez-Vidal María José,Molina Áurea,Anido Urbano,Chirivella Isabel,Etxaniz Olatz,Fernández-Parra Eva,Guix Marta,Hernández Carolina,Lambea Julio,Montesa Álvaro,Pinto Álvaro,Ros Silverio,Gallardo Enrique

Funder

Novartis

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/s40360-018-0264-8.pdf

Reference73 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

2. Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M et al. The Global Burden of Cancer 2013. JAMA oncology. 2015;1:505–527.

3. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604–14.

4. Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;183:1309–15.

5. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30:843–52.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma;Bioorganic Chemistry;2024-10

2. Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer;Bioorganic Chemistry;2024-06

3. Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma;Biomedicines;2024-05-16

4. Desmoid Tumors: Current Perspective and Treatment;Current Treatment Options in Oncology;2024-01-25

5. The role of belzutifan, an inhibitor of hypoxia-inducible factor, for renal cell carcinoma in adults with Von Hippel–Lindau disease: a review;Drugs & Therapy Perspectives;2023-11